Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Erasca Stock

erasca.comHealthcareFounded: 2018Funding to Date: $64MM

Erasca is a biotechnology company committed to solving oncology’s hardest problems.

Learn more about Erasca IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Erasca.

Register Today

Team

Management Team

Gary Yeung

Chief Business Officer

Jonathan Lim MD

Founder and Executive Chairman

Board Members

James Bristol Ph.D

Jonathan Lim MD

Pratik Multani MD

Alexander Casdin

Other companies like Erasca in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

News

Crunchbase 08/31/2020

Erasca Brings In $36M More For Series B For Cancer Treatments

Erasca will use the funding to drive corporate development efforts and further advance the company’s in-house drug discovery pipeline.

Crunchbase 04/27/2020

San Diego’s Erasca Lands $200M In Series B Round

San Diego-based cancer treatment startup Erasca raised $200 million in a new round of funding, the company announced Monday.

FINSMES 04/27/2020

Erasca Raises $200M in Series B Financing | FinSMEs

Erasca, a San Diego, CA-based develper of oncology programs, completed a $200m Series B financing round co-led by Arch Venture Partners and Cormorant Asset Management

Frequently Asked Questions